Cargando…
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Disseminated disease is present in ≈50% of colorectal cancer patients upon diagnosis, being responsible for most of cancer deaths. Addition of biological drugs, as Bevacizumab, to chemotherapy, has increased progression free survival and overall survival of metastatic colorectal cancer (mCRC) patien...
Autores principales: | de Miguel Pérez, Diego, Rodriguez Martínez, Alba, Ortigosa Palomo, Alba, Delgado Ureña, Mayte, Garcia Puche, Jose Luis, Robles Remacho, Agustín, Exposito Hernandez, José, Lorente Acosta, Jose Antonio, Ortega Sánchez, Francisco Gabriel, Serrano, Ma Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055306/ https://www.ncbi.nlm.nih.gov/pubmed/32132553 http://dx.doi.org/10.1038/s41598-020-60212-1 |
Ejemplares similares
-
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
por: Delgado-Ureña, Mayte, et al.
Publicado: (2018) -
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
por: Garrido-Navas, Carmen, et al.
Publicado: (2019) -
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
por: Rodríguez-Martínez, Alba, et al.
Publicado: (2019) -
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs
por: Puche-Sanz, Ignacio, et al.
Publicado: (2017) -
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
por: de Miguel-Perez, Diego, et al.
Publicado: (2023)